Comparative Study
doi: 10.1089/jop.1994.10.289.
Loteprednol etabonate: comparison with other steroids in two models of intraocular inflammation
Affiliations
- PMID: 8207332
- DOI: 10.1089/jop.1994.10.289
Item in Clipboard
Comparative Study
Loteprednol etabonate: comparison with other steroids in two models of intraocular inflammation
J Ocul Pharmacol.
1994 Spring.
Abstract
Loteprednol etabonate (LE) is a novel steroid with a low tendency to raise IOP. It is metabolized in the eye to an inactive metabolite. The current study was undertaken to assess the intra-ocular anti-inflammatory activity of LE in two models of experimental uveitis in rabbits. In the endotoxin induced rabbit model, LE was effective at reducing measures of inflammation, but less so that either fluorometholone (FML) or dexamethasone. In the Freunds adjuvant chronic uveitis model, FML was also very effective with LE and dexamethasone showing similar activity. The data demonstrate that LE is effective at reducing intra-ocular inflammation.
Similar articles
-
Comparison of topical steroids for acute anterior uveitis.J Ocul Pharmacol Ther. 2004 Dec;20(6):533-47. doi: 10.1089/jop.2004.20.533. J Ocul Pharmacol Ther. 2004. PMID: 15684812
-
Controlled evaluation of loteprednol etabonate and prednisolone acetate in the treatment of acute anterior uveitis. Loteprednol Etabonate US Uveitis Study Group.Am J Ophthalmol. 1999 May;127(5):537-44. doi: 10.1016/s0002-9394(99)00034-3. Am J Ophthalmol. 1999. PMID: 10334346 Clinical Trial.
-
Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study.J Cataract Refract Surg. 2002 Jan;28(1):93-9. doi: 10.1016/s0886-3350(01)01185-3. J Cataract Refract Surg. 2002. PMID: 11777716 Clinical Trial.
-
Loteprednol etabonate ophthalmic suspension 0.5 %: efficacy and safety for postoperative anti-inflammatory use.Int Ophthalmol. 2012 Oct;32(5):507-17. doi: 10.1007/s10792-012-9589-2. Epub 2012 Jun 16. Int Ophthalmol. 2012. PMID: 22707339 Free PMC article. Review.
-
Loteprednol etabonate: a review of ophthalmic clinical studies.Pharmazie. 2000 Mar;55(3):178-83. Pharmazie. 2000. PMID: 10756536 Review.
Cited by
-
Ocular allergy guidelines: a practical treatment algorithm.Drugs. 2002;62(11):1611-34. doi: 10.2165/00003495-200262110-00004. Drugs. 2002. PMID: 12109924 Review.
-
Synthesis and pharmacology of anti-inflammatory steroidal antedrugs.Chem Rev. 2008 Dec;108(12):5131-45. doi: 10.1021/cr068203e. Chem Rev. 2008. PMID: 19035773 Free PMC article. Review. No abstract available.
-
Safety and efficacy of twice daily administration of KPI-121 1% for ocular inflammation and pain following cataract surgery.Clin Ophthalmol. 2018 Dec 27;13:69-86. doi: 10.2147/OPTH.S185800. eCollection 2019. Clin Ophthalmol. 2018. PMID: 30643381 Free PMC article.
-
Use of loteprednol for routine prophylaxis after photorefractive keratectomy.Clin Ophthalmol. 2012;6:653-9. doi: 10.2147/OPTH.S30282. Epub 2012 May 1. Clin Ophthalmol. 2012. PMID: 22570546 Free PMC article.
-
Safety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgery.Clin Ophthalmol. 2011;5:177-86. doi: 10.2147/OPTH.S16832. Epub 2011 Feb 10. Clin Ophthalmol. 2011. PMID: 21383946 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources